glp 1 fda compounding regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight-loss and peptide products. An FDA warning letter to ProRx states the company continued FDA announces plans to restrict

This, in combination with the blood sugar-lowering effects of GLP-1 medications can make your blood sugar drop too low (especially if you're taking other diabetes medications), making it dangerous

Possible Role of TMAO in Promoting AS Below, we discuss the TMAO-involved mechanisms of AS from the perspectives of immunity, inflammation, cholesterol metabolism, and atherothrombosis ( Figure 1 )

In addition, Bissinger et al

Not recommended during pregnancy or while breastfeeding

But researchers have noticed that GLP-1 receptor agonists also have systemic effects beyond blood sugar and appetite, including anti-inflammatory properties